openPR Logo
Press release

Sun Pharma Share Price - Sun Pharma Share Price Live Update - mymoneykarma

09-04-2018 10:02 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: mymoneykarma

Sun Pharmaceutical is a premier medicine provider in India and worldwide. In 1983, Dilip Shanghvi founded the company; the company principally deals in medicines about diabetology, cardiology, neurology, et cetera. In the 50 years since its establishment, the Sun Pharma has incorporated manufacturing units across the globe and completed several acquisitions in the process. Apart from providing formulations that are used in tablets, creams, capsules, et cetera, the company has also developed its range of Active Pharmaceutical Ingredients (API). Their market share in India is presently the highest while in the US; they are in the fifth place. The company's vision is to touch lives globally as a leading provider of valued medicines.

History of Sun Pharmaceuticals:
In 1983, the Sun Pharmaceuticals was established by Mr. Shanghvi in Vapi. He began the company with just five products to treat disorders related to psychiatry, at the time. During that decade, the products related to cardiology and gastroenterology were also launched. As the company expanded, it started manufacturing products in other therapy areas as well, like neurology, gynecology, oncology, et cetera. It has also set up its R&D division knowing the importance of researching the field of medicines.

Sun Pharma has also set up API and formulation plants across the globe as per the international standards. The company have also been approved by USFDA and UK MHRA (Regulatory agency related to medicine and healthcare.

Click here to Know the Live Update of SUN PHARMA @ https://www.mymoneykarma.com/share-market/sunpharma.html

Listing and Indices of Sun Pharmaceutical Industries :
The company is traded on the two major stock exchanges in India - NSE, and BSE. The Sun Pharmaceutical Industries is also part of the other major market indices in India like BSE SENSEX and NIFTY 50. Though there are many pharma companies on NIFTY, only two pharma companies are on SENSEX with Sun Pharma being one of them. Along with these indices, the Sun Pharma is also a part of S&P CNX 500, BSE 100 and BSE 200.

About MyMoneyKarma: MyMoneyKarma is emerging as a leading Recommender Engine that helps people makes Intelligent Financial decisions. We are founded by two Stanford Business School alumni who bring decades of experience in Consumer Finance and Technology. Our focus is on creating secure, data-driven, unbiased, and consumer-friendly online tools that recommend products and services in a rapidly evolving environment. We use Machine Learning algorithms to identify potential opportunities for our customers to plan, save and invest.

Plot No:56, Anupama Homes, Emerald Gardens, Nanakramguda Gachibowli, 5Min from Wipro Circle, Nanakram Guda, Hyderabad, Telangana 500008

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sun Pharma Share Price - Sun Pharma Share Price Live Update - mymoneykarma here

News-ID: 1217008 • Views: 587

More Releases from mymoneykarma

How to save for a down payment?
How to save for a down payment? The very first step towards buying a home is saving for it. Saving for this requires a lot of discipline and perseverance, for it involves putting aside money for your future. Additionally, you also need to know or need to have the knowledge of where to invest your money. Should you use a bank, an online savings account, or the stock market? “How
MyMoneyKarma Takes Indian Home Loan And Mortgage Market by Storm With Proprietar …
India-based FinTech firm vastly simplifies the complex personal finance industry in India with its latest launch June 7, 2021, Home Loan, Personal Finance, FinTech Press Release from: MyMoneyKarma.com MyMoneyKarma, one of India’s fastest growing FinTech firms, has successfully launched a full-suite digital platform in an expanded range of financial products, which now include everything fromHomeLoans(@https://www.mymoneykarma.com/home-loan.html), Personal Loans and Gold Loans, to Loans Against Property, and Refinancing existing loans. Proprietary technology empowers MyMoneyKarma’s customers
PNB Stock Trends in 2018 - PNB Share Price Live Update - mymoneykarma
PNB share price fluctuates at every moment and thus it is very important for all potential investors to keenly study the performance of the company’s shares before investing in it. PNB shares can be purchased from NSE (National Stock Exchange) as well as from BSE (Bombay Stock Exchange). All the details regarding the PNB stock price, PE ratio, earlier closings and other metrics that can help in judging the stocks
ICICI Bank Share Price - ICICI Bank Share Price Live Update - mymoneykarma
On 31 January 2018, the share price stood at Rs.348.85. The month of February saw a decline in share prices. On 1 February 2018, ICICI Bank share price was Rs.347.55. By 05 February 2018, the share price dropped to RS.327.60. The price fall was mainly due to selling pressure. On 9th and 10th of the month, prices dropped further, and on the 14th it recorded the lowest rate of the month Rs.327. On 01

All 4 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications